tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NUVB Stock Latest News

Nuvation Bio enrolls first patient in TRUST-IV Phase 3 study of IBTROZI
The FlyNuvation Bio enrolls first patient in TRUST-IV Phase 3 study of IBTROZI
9d ago
NUVB
Nuvation Bio’s Strategic Growth Potential and Promising Pipeline Justify Buy Rating
PremiumRatings
Nuvation Bio’s Strategic Growth Potential and Promising Pipeline Justify Buy Rating
9d ago
NUVB
Nuvation Bio initiated with a Buy at Jefferies
PremiumThe Fly
Nuvation Bio initiated with a Buy at Jefferies
9d ago
NUVB
Nuvation Bio announces Japan MHLW approval for Ibtrozi
PremiumThe Fly
Nuvation Bio announces Japan MHLW approval for Ibtrozi
20d ago
NUVB
Nuvation Bio’s Phase 3 Study on Taletrectinib: A Potential Game-Changer for NSCLC Treatment
PremiumCompany Announcements
Nuvation Bio’s Phase 3 Study on Taletrectinib: A Potential Game-Changer for NSCLC Treatment
1M ago
NUVB
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for Glioma Treatment
PremiumCompany AnnouncementsNuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for Glioma Treatment
1M ago
NUVB
Nuvation Bio announces new data from Phase 2 studies of IBTROZI
Premium
The Fly
Nuvation Bio announces new data from Phase 2 studies of IBTROZI
1M ago
NUVB
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for IDH1 Mutant Glioma
Premium
Company Announcements
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for IDH1 Mutant Glioma
2M ago
NUVB
Nuvation Bio’s Milestone with FDA Approval of IBTROZI
PremiumCompany Announcements
Nuvation Bio’s Milestone with FDA Approval of IBTROZI
2M ago
NUVB
Positive Market Trajectory and Promising Developments Drive Buy Rating for Nuvation Bio
PremiumRatings
Positive Market Trajectory and Promising Developments Drive Buy Rating for Nuvation Bio
2M ago
NUVB
Promising Outlook for Nuvation Bio: Buy Rating Backed by Ibtrozi’s Market Success and Future Prospects
PremiumRatings
Promising Outlook for Nuvation Bio: Buy Rating Backed by Ibtrozi’s Market Success and Future Prospects
2M ago
NUVB
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Breakthrough for IDH1 Mutant Glioma
PremiumCompany Announcements
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Breakthrough for IDH1 Mutant Glioma
3M ago
NUVB
3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
PremiumMarket News3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
3M ago
AURA
NUVB
Nuvation Bio management to meet virtually with B. Riley
Premium
The Fly
Nuvation Bio management to meet virtually with B. Riley
3M ago
NUVB
Nuvation Bio management to meet with B. Riley
Premium
The Fly
Nuvation Bio management to meet with B. Riley
3M ago
NUVB
Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
PremiumRatings
Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
4M ago
NUVB
Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
PremiumThe Fly
Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
4M ago
NUVB
Nuvation Bio price target lowered to $6 from $10 at RBC Capital
PremiumThe Fly
Nuvation Bio price target lowered to $6 from $10 at RBC Capital
4M ago
NUVB
Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
PremiumRatings
Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
4M ago
NUVB
Nuvation Bio’s IBTROZI Receives FDA Approval
PremiumCompany AnnouncementsNuvation Bio’s IBTROZI Receives FDA Approval
4M ago
8K
NUVB
Nuvation Bio down 9% after FDA approves Ibtrozi
Premium
The Fly
Nuvation Bio down 9% after FDA approves Ibtrozi
4M ago
NUVB
Warnings for Nuvation’s Ibtrozi as expected, says JonesResearch
Premium
The Fly
Warnings for Nuvation’s Ibtrozi as expected, says JonesResearch
4M ago
NUVB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >